Clinical trial
A Multicenter Prospective Randomized Controlled Trial of the Effectiveness of Amantadine Hydrochloride in Promoting Recovery of Function Following Severe Traumatic Brain Injury
NCT00970944 is registered in ClinicalTrials.gov with JFK Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter Prospective Randomized Controlled Trial of the Effectiveness of Amantadine Hydrochloride in Promoting Recovery of Function Following Severe Traumatic Brain Injury
- Lead sponsor
- JFK Medical Center
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- February 28, 2003
- Completion date
- March 31, 2010
- Enrollment
- 184 (actual)
- Sites
- 11
Conditions
As the registry lists them; a condition with its own page is linked.
traumatic brain injury